You just read:

Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness

News provided by

Jazz Pharmaceuticals plc

Apr 26, 2017, 16:05 ET